We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.60 | -0.81% | 73.60 | 73.60 | 74.00 | 74.40 | 73.60 | 74.00 | 1,676 | 14:38:32 |
Hot Features
Premium
RNS Number:3019R
CeNeS Pharmaceuticals PLC
24 October 2003
CENES PHARMACEUTICALS PLC ("the Company")
HOLDING IN COMPANY
The Company was informed on 23 October 2003 by M&G Investment Management
Limited, that Prudential plc has an interest in 14,500,000 ordinary shares of 1p
each in the capital of the Company representing 6.85 per cent. of the issued
share capital of the Company.
Further information
Neil Clark, CeNeS Pharmaceuticals plc 01223 266 466
24 October 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSRVROKRRUAA
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
